| Literature DB >> 27330784 |
Wei Chen1, Deng-Jun Han1, Guang-Qing Fu1, Wei Lin1, Yong Liang1.
Abstract
Prostate sarcoma, particularly the pathological type of leiomyosarcoma, is a rare carcinoma, which originated from the interstitial tissue of the prostate. This sarcoma type has a poor prognosis. This disease accounts for ~0.1% of all prostate cancer and it usually occurrs in patients aged between 40 and 78-years-old. Although prostate leiomyosarcoma has a poor prognosis, early treatment of post-operative recurrence and metastases via a whole-body examination and closer follow-up was possible. These measurements may significantly prolong the survival time and improve the quality of life. The present study reported a successful case of surgical management for prostate leiomyosarcoma in the Zigong No. 4 People's Hospital (Sichuan, China) during 1995 until 2015, with post-operative follow-up for 20 years.Entities:
Keywords: immunohistochemistry; leiomyosarcoma; prognosis; prostate; sarcoma
Year: 2016 PMID: 27330784 PMCID: PMC4906952 DOI: 10.3892/mco.2016.898
Source DB: PubMed Journal: Mol Clin Oncol ISSN: 2049-9450